Abstract:Efforts to develop vaccines for prevention of acute diarrhea have been going on for more than 40 y with partial success. The myriad of pathogens, more than 20, that have been identified as a cause of acute diarrhea throughout the years pose a significant challenge for selecting and further developing the most relevant vaccine candidates. Based on pathogen distribution as identified in epidemiological studies performed mostly in low-resource countries, rotavirus, Cryptosporidium, Shigella, diarrheogenic E. coli and V. cholerae are predominant, and thus the main targets for vaccine development and implementation. Vaccination against norovirus is most relevant in middle/high-income countries and possibly in resource-deprived countries, pending a more precise characterization of disease impact. Only a few licensed vaccines are currently available, of which rotavirus vaccines have been the most outstanding in demonstrating a significant impact in a short time period. This is a comprehensive review, divided into 2 articles, of nearly 50 vaccine candidates against the most relevant viral and bacterial pathogens that cause acute gastroenteritis. In order to facilitate reading, sections for each pathogen are organized as follows: i) a discussion of the main epidemiological and pathogenic features; and ii) a discussion of vaccines based on their stage of development, moving from current licensed vaccines to vaccines in advanced stage of development (in phase IIb or III trials) to vaccines in early stages of clinical development (in phase I/II) or preclinical development in animal models. In this first article we discuss rotavirus, norovirus and Vibrio cholerae. In the following article we will discuss Shigella, Salmonella (non-typhoidal), diarrheogenic E. coli (enterotoxigenic and enterohemorragic), and Campylobacter jejuni.

The Pivotal Mechanism and Organizational Control

Advanced Grid Management Software for Seamless Services

[Vaccination against diarrheal diseases and typhoid fever. Current status and prospects]

Progress and Hurdles in the Development of Vaccines Against Enterotoxigenicescherichia Coliin Humans

Volume replacement with Ringer-lactate is detrimental in severe hemorrhagic shock but protective in moderate hemorrhagic shock: studies in a rat model

Progress in enteric vaccine development

Future Vaccines Against Enteric Pathogens

Vaccines against cholera, typhoid fever and shigellosis for developing countries

Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part I: Overview, vaccines for enteric viruses and Vibrio cholerae

Enteric infections and the vaccines to counter them: Future directions

Oral vaccination against enteric bacterial infections: An overview

Current Progress in Developing Subunit Vaccines Against Enterotoxigenic Escherichia Coli-Associated Diarrhea

Update on vaccines for enteric pathogens

Evaluation of Eight Preservation Solutions for Endothelial in situ Preservation

Combination vaccines against diarrheal diseases

Vaccines for the prevention of diarrhea due to cholera, shigella, ETEC and rotavirus

Improving immunization approaches to cholera

A phase I/IIa clinical trial of CLAOP21 and CLAOP14 in patients with high-grade non-Hodgkin's lymphoma and cardiac risk factors.

Are "Patellofemoral Symptoms" Truly Related to the Patellofemoral Joint?

Vaccine development for enteric bacterial pathogens: Where do we stand?

Live oral vaccines against cholera: An update